Human Milk Oligosaccharides Market Research Report - Global Forecast till 2027

Global Human Milk Oligosaccharides Market Information: Information by Type (Neutral and Acidic), Application (Food Industry and Laboratory Research) and Region (North America, Europe, China and Japan) - Forecast till 2027

ID: MRFR/F-B & N/6372-CR | June 2019 | Region: Global | 88 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data.

Market Overview


The Global Human Milk Oligosaccharides Market is Expected to Register a CAGR of 27.06% During the Assessment Period with a Market Value of USD 110.03 Million in 2018.


Human milk oligosaccharides (HMOs) are sugar molecules found in high concentrations in breast milk. They are the third most abundant ingredient in human breast milk, after fats and carbohydrates. The global human milk oligosaccharides market is growing due to the increasing application of HMOs in functional foods and rising demand in infant formula. However, the high cost of production is hampering the growth of the global human milk oligosaccharides market.


Market Dynamics


Over the past few years, rising health consciousness has led to radical changes in lifestyles and diet, driving the demand for functional foods, such as dietary supplements and probiotics, globally. The use of HMOs in adult nutrition such as functional foods and supplements is increasing due to their benefits such as improving gut microbiota and boosting the immune system. The addition of HMOs in functional food products and beverages not only promotes the growth of good bacteria but can also eliminate harmful bacteria such as salmonella and campylobacter. These factors are expected to drive the growth of the market during the forecast period.


Global Human Milk Oligosaccharides Market Revenue, by Type (USD Million)  Human Milk Oligosaccharides Market_Image


Source: MRFR Analysis


Segmentation


The global human milk oligosaccharides market has been segmented on the basis of type, application, and region.


The global human milk oligosaccharides market has been segmented, based on type, into neutral and acidic. The neutral segment is projected to reach USD 563.13 Million by 2025. On the basis of application, the global human milk oligosaccharides market has been divided into food industry and laboratory research.


Key Players


The prominent players in the global human milk oligosaccharides market are Abbott (US), BASF SE (Germany), Dextra Laboratories Limited (UK), DuPont Nutrition & Health (Denmark), Elicityl S.A. (France), Glycom (Denmark), Glycosyn LLC (US), Inbiose NV (Belgium), Jennewein Biotechnologie GmbH (Germany), Medolac Laboratories (US), Nestlé Health Science (Switzerland) and ZuChem (US).


Some of the key strategies followed by the players operating in the global human milk oligosaccharides market were innovations, product developments, acquisitions, and mergers.


Global Human Milk Oligosaccharides Market Share, 2018 (%)  Human Milk Oligosaccharides Market_Image


Source: MRFR Analysis


Regional Analysis


The global human milk oligosaccharides market has been divided, based on region, into North America, Europe, China, and Japan.


In 2018, North America accounted for the largest share of the global human milk oligosaccharides market due to the high consumption of infant formula in the region. In 2018, the European human milk oligosaccharides market accounted for the second-largest revenue share of the global market. According to a 2017 report published by UNICEF, the UK has one of the lowest rates of breastfeeding in the world, with just 34% of babies receiving breast milk at six months of age. Therefore, the key factors influencing the growth of the European market are the low rates of breastfeeding and rising EU approvals for newly launched HMO-based products. Japan held the smallest share of the global human milk oligosaccharides market due to the decline in infant population; the Japanese market accounted for a share of 3.26% in 2018.


Industry Updates



  • In May 2019, Glycosyn LLC and BASF SE signed an agreement for the development and commercialization of HMOs for widespread use in dietary supplements, functional nutrition, and medical food. As part of the collaboration and under the exclusive license, BASF SE will extend its offering of the most abundant HMO, 2’-Fucosyllactose (2’-FL) branded PREBILACTM, to emerging markets.



  • In November 2018, Glycosyn LLC and Ginkgo Bioworks announced a USD 14 million agreement to optimize and scale the production of HMOs for a set of products that offer health benefits by fostering a healthy gut microbial ecology.



  • In October 2018, Inbiose NV announced that it had extended its offering to seven HMOs for which efficient processes have become available for large-scale manufacturing and commercialization.


Market Segmentation


Global Human Milk Oligosaccharides Market, by Type



  • Acidic

  • Neutral


Global Human Milk Oligosaccharides Market, by Application



  • Food Industry

  • Laboratory Research


Global Human Milk Oligosaccharides Market, by Region



  • North America

  • Europe

  • China

  • Japan


Available Additional Customizations



  • Human Milk Oligosaccharides Market, by Americas Region

  • Human Milk Oligosaccharides Market, by Asia-Pacific Region

  • Human Milk Oligosaccharides Market, by Middle East & Africa Region

  • Human Milk Oligosaccharides Market, Technology Trends and Assessment


Intended Audience



  • Pharmaceutical companies

  • Research and development organizations

  • Academic institutes

  • Food & beverage manufacturers



Frequently Asked Questions (FAQ) :


Human milk oligosaccharides market is projected to grow at approximately 27.06 %CAGR during the assessment period (2019-2025).

Human milk oligosaccharides market is estimated to reach a valuation of approx. USD 110.03 MN by the end of 2025.

Rising awareness for benefits such as improving gut microbiota that boost the immune system, are the major tailwinds pushing the growth of the global Human milk oligosaccharides market.

North America holds the largest share in the global human milk oligosaccharides market, followed by Europe and the Asia Pacific, respectively.

Abbott (US), Dextra Laboratories Limited (UK), BASF SE (Germany), DuPont Nutrition & Health (Denmark), Glycom (Denmark), Elicityl S.A. (France), Glycosyn LLC (US), Jennewein Biotechnologie GmbH (Germany), Inbiose NV (Belgium), Medolac Laboratories (US), ZuChem (US), and Nestlé Health Science (Switzerland), are some of the top players operating in the global human milk oligosaccharides market.

1 Executive Summary

2 Market Introduction

2.1 Definition 11

2.2 Scope of the Study 11

2.3 Market Structure 11

3 Research Methodology

3.1 Research Process 12

3.2 Primary Research 13

3.3 Secondary Research 14

3.4 Market Size Estimation 15

3.5 Forecast Model 15

4 Market Dynamics

4.1 Overview 16

4.2 Drivers 17

4.2.1 Rising Application in Functional Foods 17

4.2.2 Increasing Demand in Infant Formula 17

4.3 Restraint 18

4.3.1 High Production Costs 18

4.4 Opportunity 18

4.4.1 Expansion in Emerging Economies 18

5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis 19

5.1.1 Threat of New Entrants 20

5.1.2 Bargaining Power of Suppliers 20

5.1.3 Threat of Substitutes 20

5.1.4 Bargaining Power of Buyers 20

5.1.5 Rivalry 20

6 Human Milk Oligosaccharides Market, by Type

6.1 Overview 21

6.2 Neutral 23

6.3 Acidic 24

7 Human Milk Oligosaccharides Market, by Application

7.1 Overview 25

7.2 Food Industry 26

7.3 Laboratory Research 27

8 Global Human Milk Oligosaccharides Market, by Region/Country

8.1 Overview 28

8.2 North America 30

Human Milk Oligosaccharides Market, by Type

Human Milk Oligosaccharides Market, by Application

8.3 Europe 31

Human Milk Oligosaccharides Market, by Type

Human Milk Oligosaccharides Market, by Application

8.4 China 32

Human Milk Oligosaccharides Market, by Type

Human Milk Oligosaccharides Market, by Application

8.5 Japan 33

Human Milk Oligosaccharides Market, by Type

Human Milk Oligosaccharides Market, by Application

9 Competitive Landscape

9.1 Overview 34

10 Company Profiles

10.1 Abbott 35

10.1.1 Company Basic Information and Headquarters 35

10.1.2 Financial Overview 35

10.1.3 Products Offered 35

10.1.4 Main Business/Business Overview 36

10.2 Inbiose 37

10.2.1 Company Basic Information and Headquarters 37

10.2.2 Financial Overview 37

10.2.3 Products Offered 37

10.2.4 Main Business/Business Overview 37

10.3 Jennewein Biotechnologie GmbH 38

10.3.1 Company Basic Information and Headquarters 38

10.3.2 Financial Overview 38

10.3.3 Products Offered 38

10.3.4 Main Business/Business Overview 38

10.4 Glycom 39

10.4.1 Company Basic Information and Headquarters 39

10.4.2 Financial Overview 39

10.4.3 Products Offered 39

10.4.4 Main Business/Business Overview 39

10.5 ZuChem 40

10.5.1 Company Basic Information and Headquarters 40

10.5.2 Financial Overview 40

10.5.3 Products Offered 40

10.5.4 Main Business/Business Overview 40

10.6 Dextra Laboratories 41

10.6.1 Company Basic Information and Headquarters 41

10.6.2 Financial Overview 41

10.6.3 Products Offered 41

10.6.4 Main Business/Business Overview 41

10.7 DuPont Nutrition 42

10.7.1 Company Basic Information and Headquarters 42

10.7.2 Financial Overview 42

10.7.3 Products Offered 42

10.7.4 Main Business/Business Overview 42

10.8 Elicityl S.A. 43

10.8.1 Company Basic Information and Headquarters 43

10.8.2 Financial Overview 43

10.8.3 Products Offered 44

10.8.4 Main Business/Business Overview 44

10.9 Glycosyn LLC 45

10.9.1 Company Basic Information and Headquarters 45

10.9.2 Financial Overview 45

10.9.3 Products Offered 45

10.9.4 Main Business/Business Overview 45

10.10 Medolac Laboratories 46

10.10.1 Company Basic Information and Headquarters 46

10.10.2 Financial Overview 46

10.10.3 Products Offered 46

10.10.4 Main Business/Business Overview 46

11 Appendix

11.1 References 47

11.2 Related Reports 47

12 List of Tables

TABLE 1 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2021-2027 (USD MILLION) 22

TABLE 2 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR NEUTRAL HMO, BY REGION, 2021-2027 (USD MILLION) 23

TABLE 3 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR ACIDIC HMO, BY REGION, 2021-2027 (USD MILLION) 24

TABLE 4 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 26

TABLE 5 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR FOOD INDUSTRY, BY REGION, 2021-2027 (USD MILLION) 26

TABLE 6 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET FOR LABORATORY RESEARCH, BY REGION, 2021-2027 (USD MILLION) 27

TABLE 7 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION/COUNTRY, 2021-2027 (USD MILLION) 29

TABLE 8 NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2021-2027 (USD MILLION) 30

TABLE 9 NORTH AMERICA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 30

TABLE 10 EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2021-2027 (USD MILLION) 31

TABLE 11 EUROPE: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 31

TABLE 12 CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2021-2027 (USD MILLION) 32

TABLE 13 CHINA: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 32

TABLE 14 JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2021-2027 (USD MILLION) 33

TABLE 15 JAPAN: HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2021-2027 (USD MILLION) 33

TABLE 16 TOP MANUFACTURERS IN THE GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET 34

TABLE 17 ABBOTT: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 35

TABLE 18 ABBOTT: FINANCIAL OVERVIEW 35

TABLE 19 INBIOSE: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 37

TABLE 20 JENNEWEIN BIOTECHNOLOGIE GMBH: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 38

TABLE 21 GLYCOM: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 39

TABLE 22 ZUCHEM: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 40

TABLE 23 DEXTRA LABORATORIES: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 41

TABLE 24 DUPONT NUTRITION: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 42

TABLE 25 DUPONT NUTRITION: FINANCIAL OVERVIEW 42

TABLE 26 ELICITYL S.A.: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 43

TABLE 27 GLYCOSYN LLC: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 45

TABLE 28 MEDOLAC LABORATORIES: PRODUCTS, BASIC INFORMATION, AND HEADQUARTERS 46

13 List of Figures

List of Figures

FIGURE 1 MARKET SYNOPSIS 10

FIGURE 2 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET: MARKET STRUCTURE 11

FIGURE 3 RESEARCH PROCESS OF MRFR 12

FIGURE 4 TOP-DOWN & BOTTOM-UP APPROACHES 15

FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET 16

FIGURE 6 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET 19

FIGURE 7 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2021 (%) 21

FIGURE 8 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY TYPE, 2021 AND 2027 (USD MILLION) 21

FIGURE 9 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2021 (%) 25

FIGURE 10 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY APPLICATION, 2021 AND 2027 (USD MILLION) 25

FIGURE 11 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION/COUNTRY, 2021 (%) 28

FIGURE 12 GLOBAL HUMAN MILK OLIGOSACCHARIDES MARKET, BY REGION/COUNTRY, 2021 AND 2027 (USD MILLION) 29